BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Eishiro Mizukoshi, Shuichi Kaneko. Immune cell therapy for hepatocellular carcinomaJournal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0742-5
2
Shun-Zhen Zheng, Ping Sun, Jian-Ping Wang, Yong Liu, Wei Gong, Jun Liu. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cellsWorld Journal of Gastroenterology 2019; 25(22): 2752-2762 doi: 10.3748/wjg.v25.i22.2752
3
Hendra Susanto, Chih-Hong Wang, Aulanni’am Aulanni’am, Adeodatus Yuda Handaya. Enhancing early stage of hepatocellular carcinoma: Does correlate to MicroRNA 122 and miR196a interaction?INTERNATIONAL CONFERENCE ON BIOLOGY AND APPLIED SCIENCE (ICOBAS) 2019; 2120: 070021 doi: 10.1063/1.5115738
4
Flavia Fondevila, Carolina Méndez-Blanco, Paula Fernández-Palanca, Javier González-Gallego, José L. Mauriz. Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancersExperimental & Molecular Medicine 2019; 51(9) doi: 10.1038/s12276-019-0308-1
5
Meijuan Zheng, Zhigang Tian. Liver-Mediated Adaptive Immune ToleranceFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02525
6
Fat-Moon Suk, Chao-Lien Liu, Ming-Hua Hsu, Yu-Ting Chuang, Jack P. Wang, Yi-Jen Liao. Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53863-2
7
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and ChallengesCancers 2019; 11(10): 1554 doi: 10.3390/cancers11101554
8
Ziyu Liu, Yan Lin, Jinyan Zhang, Yumei Zhang, Yongqiang Li, Zhihui Liu, Qian Li, Ming Luo, Rong Liang, Jiazhou Ye. Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1412-8
9
Pei-Chang Lee, Yee Chao, Ming-Huang Chen, Keng-Hsin Lan, Chieh-Ju Lee, I-Cheng Lee, San-Chi Chen, Ming-Chih Hou, Yi-Hsiang Huang. Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular CarcinomaCancers 2020; 12(1): 182 doi: 10.3390/cancers12010182
10
Akihisa Ueno, Yohei Masugi, Ken Yamazaki, Yutaka Kurebayashi, Hanako Tsujikawa, Kathryn Effendi, Hidenori Ojima, Michiie Sakamoto. Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinomaPathology International 2020;  doi: 10.1111/pin.12895
11
Hon-Ping Ma, Hang-Lung Chang, Oluwaseun Adebayo Bamodu, Vijesh Kumar Yadav, Ting-Yi Huang, Alexander T. H. Wu, Chi-Tai Yeh, Shin-Han Tsai, Wei-Hwa Lee. Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and MetastasisCancers 2019; 11(6): 786 doi: 10.3390/cancers11060786
12
Yoshito Tomimaru, Arihiro Aihara, Jack R. Wands, Costica Aloman, Miran Kim. A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 IsoformTranslational Oncology 2019; 12(10): 1345 doi: 10.1016/j.tranon.2019.07.002
13
Ann-Lii Cheng, Chiun Hsu, Stephen L. Chan, Su-Pin Choo, Masatoshi Kudo. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinomaJournal of Hepatology 2020; 72(2): 307 doi: 10.1016/j.jhep.2019.09.025
14
Maria Tampaki, Evangelos Ionas, Emilia Hadziyannis, Melanie Deutsch, Katerina Malagari, John Koskinas. Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular CarcinomaCancers 2020; 12(1): 212 doi: 10.3390/cancers12010212
15
Wafaa M. Rashed, Mohamed Ahmed Mohamed Kandeil, Mohamed O. Mahmoud, Sameera Ezzat. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overviewJournal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-0016-x
16
Hendrik Reynaert, Isabelle Colle. Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the LiteratureInternational Journal of Molecular Sciences 2019; 20(19): 4811 doi: 10.3390/ijms20194811
17
Hong Zhao, Yujie Wang, Yufeng Liu, Xiaohua Hao, Hongshan Wei, Wen Xie. The Effect of Protein FAM172A on Proliferation in HepG2 Cells and Investigation of the Possible Molecular MechanismAnalytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/5901083